Dr Reddy’s Mexico API facility gets two observations from USFDA

The assessment covered manufacturing records and documentation, with the company saying it will respond to the regulator within the stipulated timeline.
Key takeaways
- Category: Company.
Why it matters
A routine update. Use the price and stock snapshot to gauge how the market is responding.






